| Dr Raymond Lorenz, PHARMD | |
|
2400 Gordon Smith Dr, Mobile, AL 36617-2319 | |
| (251) 450-1388 | |
| Not Available |
| Full Name | Dr Raymond Lorenz |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Psychiatric |
| Location | 2400 Gordon Smith Dr, Mobile, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013101666 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P1300X | Pharmacist - Psychiatric | 15619 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raymond Lorenz, PHARMD 2400 Gordon Smith Dr, Mobile, AL 36617-2319 Ph: (251) 450-1388 | Dr Raymond Lorenz, PHARMD 2400 Gordon Smith Dr, Mobile, AL 36617-2319 Ph: (251) 450-1388 |
News Archive
Researchers at the National Institute of Standards and Technology (NIST) and three collaborating institutions are using a new laboratory model of the membrane surrounding neurons in the brain to study how a protein long suspected of a role in early-stage Alzheimer's disease actually impairs a neuron's structure and function.
U.S. children's hospitals delivering the highest-quality care for children undergoing heart surgery, also appear to provide care most efficiently at a low cost, according to research led by the University of Michigan and presented Tuesday at the American Heart Association Scientific Sessions in Chicago.
A new study recently published in the American Journal of Transplantation reveals that the ability to successfully carry a pregnancy after kidney transplantation is very high, with 73.5% live birth rates.
Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.
Two mutations identified in individuals with developmental and epileptic brain disease can be traced back to the same ion channel.
› Verified 7 days ago
Dr. Wilfred Arcard Brown, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3948 Airport Blvd, Mobile, AL 36608 Phone: 251-345-3394 | |
Chidiya Ohiagu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1303 Dr Martin L King Jr Ave, Mobile, AL 36603 Phone: 251-432-4117 | |
Darren P Billiot, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6575 Airport Blvd, Mobile, AL 36608 Phone: 251-370-9848 | |
Eric Donaldson Reeves, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4628 Airport Blvd, Mobile, AL 36608 Phone: 251-341-5749 | |
Mr. Chuck P Whisonant, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1504 Spring Hill Ave, Mobile, AL 36604 Phone: 251-219-3754 | |
Ms. Angela F. Amos, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 251 N Bayou St, Mobile, AL 36603 Phone: 251-690-8817 |